BioStem Technologies, Inc.

BiotechnologyBiotechnologyRegenerative MedicineAllografts

📍 Pompano Beach, FL, United States• Founded 2015• <10 employees

StreetZero Signal 79

Be the first to signal interest

About BioStem Technologies, Inc.

BioStem Technologies, Inc. (OTC: BSEM) is a publicly traded biomedical innovator focused on developing, manufacturing, and commercializing advanced allograft solutions derived from perinatal tissue. The company leverages proprietary BioRetain®, CryoTek®, and SteriTek® processing technologies to optimize tissue preservation for clinical use in wound care and regenerative therapies. Its products include Vendaje, Vendaje AC, Vendaje OPTIC, American Amnion AC, and American Amnion, serving the U.S. healthcare market with a national commercial footprint. BioStem Technologies was founded in 2015 and is headquartered in Pompano Beach, Florida.

LATEST FUNDINGPrivate Placement

$40.0M

Announced 2026-09-21

TOTAL RAISED$40M

🔒

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for BioStem Technologies, Inc..

Create free account Sign in

Free plan includes 3 full deal profiles every month.

IN THE NEWS

EMPLOYEES<10

FOUNDED2015

HQPompano Beach, FL, United States

Industry

Biotechnology

Investors

Roth Principal Investments

Key highlights

Entered $40M Committed Equity Facility with Roth Principal Investments for growth capital.
Develops perinatal tissue allografts using BioRetain, CryoTek, and SteriTek technologies.
Publicly traded on OTC as BSEM with focus on wound care and regenerative therapies.
Serves U.S. healthcare market with products like Vendaje and American Amnion lines.
Sponsors community programs including Florida Panthers Heroes Among Us and Seats for Service.